Most visited

8 months ago
Kintor Pharmaceutical sees its HK$1.86 billion (US$240 million) IPO more than 500 times oversubscribed as investors keep betting on biotech start-ups to hit the jackpot with high-demand medicines.

603o

65%
Menu

Leave a Comment